Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Cancer Immunology Research|May 20, 2024
Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and MyositisBilal A Siddiqui, Nicolas L Palaskas, Sreyashi Basu, et al.
Iscience|January 15, 2026
Integrative spatial multi-omics reveal niche-specific inflammatory signaling and differentiation hierarchies in AMLEnes Dasdemir, Ivo Veletic, Christopher P Ly, et al.
Nature Medicine|December 25, 2019
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastomaSangeeta Goswami, Thomas Walle, Andrew E Cornish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T CellsChad Tang, James W Welsh, Patricia de Groot, et al.
Cancer Immunology Research|March 25, 2025
Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor OutcomeCandice C Poon, Shelley M Herbrich, Yulong Chen, et al.
NPJ Precision Oncology|May 20, 2025
Multimodal spatial proteomic profiling in acute myeloid leukemiaChristopher P Ly, Ivo Veletic, Christopher D Pacheco, et al.
The Lancet. Haematology|August 12, 2019
Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 studyFarhad Ravandi, Rita Assi, Naval Daver, et al.
Journal for Immunotherapy of Cancer|March 22, 2023
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, et al.
Blood Advances|October 26, 2022
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLLNitin Jain, Jayastu Senapati, Beenu Thakral, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2019
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancerJorge Blando, Anu Sharma, Maria Gisela Higa, et al.
Pageof 6